Hyperhomocysteinemia is a known risk factor for coronary artery disease.

Elevated levels of homocysteine have been found in a majority of patients with vascular disease.

Folic acid supplementation should be recommended to any patient who has an elevated homocysteine level.

Folic acid is easily obtained and may likely reduce vascular disease and other deleterious pathologic processes in high-risk populations.